Becton Dickinson and Company (BDX)vsKestra Medical Technologies, Ltd. Common Stock (KMTS)
BDX
Becton Dickinson and Company
$183.40
+0.79%
HEALTHCARE · Cap: $42.20B
KMTS
Kestra Medical Technologies, Ltd. Common Stock
$28.02
+1.01%
HEALTHCARE · Cap: $1.34B
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 23266% more annual revenue ($22.23B vs $95.13M). BDX leads profitability with a 5.1% profit margin vs -138.3%. BDX earns a higher WallStSmart Score of 65/100 (B-).
BDX
Strong Buy65
out of 100
Grade: B-
KMTS
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+9.2%
Fair Value
$198.97
Current Price
$183.40
$15.57 discount
Intrinsic value data unavailable for KMTS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 28.6% YoY
Revenue surging 66.2% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Moderate valuation
ROE of 3.9% — below average capital efficiency
5.1% margin — thin
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -50.3% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Price/Book, EPS Growth. PEG of 1.11 suggests the stock is reasonably priced for its growth.
Bull Case : KMTS
The strongest argument for KMTS centers on Revenue Growth, Debt/Equity. Revenue growth of 66.2% demonstrates continued momentum.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin.
Bear Case : KMTS
The primary concerns for KMTS are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
BDX profiles as a value stock while KMTS is a hypergrowth play — different risk/reward profiles.
KMTS is growing revenue faster at 66.2% — sustainability is the question.
BDX generates stronger free cash flow (276M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BDX scores higher overall (65/100 vs 28/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →Kestra Medical Technologies, Ltd. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?